SAVA

Cassava Sciences Inc.

Price

return (12m)

p/e

-0.92

p/bv

1.19

DIVIDEND YIELD

0.00%

SAVA price

Cassava Sciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment SAVA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals SAVA

Valuation

P/E

-0.92

Sector -4.39

Industry -4.39

P/BV

1.19

Sector 2.03

Industry 2.03

P/Revenue (PSR)

Sector -4.47

Industry -4.47

EV/EBITDA

0.74

Sector -265.17

Industry -265.17

EV/EBIT

0.73

Sector -704.74

Industry -704.74

P/EBITDA

-0.88

Sector -4.39

Industry -4.39

P/EBIT

-0.87

Sector -4.73

Industry -4.73

P/Total Assets

0.75

Sector 1.49

Industry 1.49

P/Net Current Assets

1.60

Sector -11.73

Industry -11.73

P/Working Capital

1.60

Sector -3.02

Industry -3.02

EPS

-2.21

Sector -2.14

Industry -2.14

BVPS

1.70

Sector 1.86

Industry 1.86

Efficiency

Gross Margin

0.00%

Sector 36.61%

Industry 36.61%

EBITDA Margin

Sector -16,313.59%

Industry -16,313.59%

EBIT Margin

Sector -4,256,416.89%

Industry -4,256,416.89%

Operating Margin

0.00%

Sector -38.06%

Industry -38.06%

Net Profit Margins

0.00%

Sector -39.54%

Industry -39.54%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-129.99%

Sector -65.39%

Industry -65.39%

ROA

-81.73%

Sector -65.45%

Industry -65.45%

ROIC

-222.22%

Sector -2,109.21%

Industry -2,109.21%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

2.27

Sector 2.90

Industry 2.90

Net Debt / EBITDA

9.04

Sector -6.09

Industry -6.09

Net Debt / EBIT

8.94

Sector -3.13

Industry -3.13

Net Debt / Equity

-1.30

Sector -1.08

Industry -1.08

Gross Debt / Equity

0.00

Sector 0.00

Industry 0.00

Equity/Assets

0.63

Sector 0.41

Industry 0.41

Liabilities/Assets

0.37

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

26.77%

Sector -

Industry -

Fundamentals SAVA

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
SAVA Cassava Sciences Inc.	$0.00	-100.00%	0.00%	-0.92	1.19	-129.99%	0.00%
JNJ Johnson & Johnson	$272.53	59.34%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.13	22.16%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$263.14	31.45%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.57	-9.78%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$150.14	85.41%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$163.92	5.55%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.12	45.89%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.85	-48.41%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$834.34	46.72%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$435.78	54.33%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$106.42	54.32%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.46	27.81%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$542.49	39.14%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$233.34	57.83%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$38.71	6.32%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$218.38	60.68%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

SAVA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	12/13/2012	12/24/2012	5.25000000
Dividends	11/29/2010	12/10/2010	14.00000000

ABOUT Cassava Sciences

Cassava Sciences Inc.

Average Investor10 user rating

4.0 (3 people)

United States

28 years

Founded: 1998

2000

Time since IPO - 26 years

11

Employees

Cassava Sciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $97.44 million, with shareholders equity totaling $81.57 million.

The company employs approximately 11 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Cassava Sciences Inc. reported $- in revenue, generating net income of $-106.03 million.

Key financial metrics include a P/E ratio of -0.92, a price-to-book (P/B) ratio of 1.19, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker SAVA.

Market cap

$97.44 million

Net worth

$81.57 million

$81,570,000.00

Assets

$129.73 million

$129,730,000.00

Total Shares Outstanding

48.00 million

48,000,000

Average Daily Trading Volume

$470.63 Thousand

$470,633.14

Sector

Health Care

Industry

Biotechnology

SAVA

SAVA revenue and profits

Financial Results SAVA

DRAG THE FRAME TO SEE MORE DATA

SAVA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.46 26,73% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$233.34 58,58% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$272.53 57,95% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$263.14 31,69% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$150.14 83,86% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$163.92 4,27% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.13 20,95% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.46 26,73% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$233.34 58,58% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$272.53 57,95% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$263.14 31,69% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$150.14 83,86% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$163.92 4,27% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.13 20,95% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Cassava Sciences (SAVA) today?

A cotação de Cassava Sciences (SAVA) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de Cassava Sciences (SAVA) iniciou o ano negociando na casa dos US$ 1.98 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Cassava Sciences (SAVA) e dados de ações do Ibovespa e mercados internacionais.

Quando Cassava Sciences (SAVA) paga dividendos?

Cassava Sciences (SAVA) não distribuiu dividendos no último ano.

Is Cassava Sciences (SAVA) a good investment?

Atualmente, Cassava Sciences (SAVA) está cotada a US$ 0.00, com um P/L de -0.92, representando um desvio de -781% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Cassava Sciences (SAVA) stock?

Investir em ações de Cassava Sciences (SAVA) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Cassava Sciences (SAVA) yield today?

A rentabilidade de Cassava Sciences (SAVA) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Cassava Sciences (SAVA) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

SAVA

Cassava Sciences Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment SAVA

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING SAVA WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

type

Ex - Dividend Date

payment date

value

ABOUT Cassava Sciences

Cassava Sciences Inc.

United States

28 years

2000

11

PROFIT X PRICE SAVA

Financial Results SAVA

SAVA cash flow

Asset, Revenue and Profit Growth - SAVA

SAVA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions